South Korea
# |
Name |
Price to Earnings Ratio (P/E) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
149.79 |
Jan. 14, 2025 | USD 33.55 | -1.07% |
|
South Korea |
|
2 |
-8.91 |
Jan. 14, 2025 | USD 3.90 | -0.31% |
|
South Korea |
|
3 |
-11.23 |
Jan. 14, 2025 | USD 10.34 | -1.02% |
|
South Korea |
|
4 |
-16.04 |
Jan. 14, 2025 | USD 1.84 | -0.37% |
|
South Korea |
|
5 |
-28.66 |
Jan. 14, 2025 | USD 8.48 | -0.62% |
|
South Korea |
|
6 |
-60.55 |
Jan. 14, 2025 | USD 108.37 | -2.33% |
|
South Korea |
The Vaccines company in South Korea with the highest Price to Earnings Ratio (P/E) is SK bioscience Co.,Ltd. (KSE: 302440.KS) at 149.79.
The Vaccines company in South Korea with the lowest Price to Earnings Ratio (P/E) is Green Cross Corporation (KSE: 006280.KS) at -60.55.
The top 10 Vaccines companies in South Korea by Price to Earnings Ratio (P/E) are SK bioscience Co.,Ltd., Cellid, Co., Ltd., Green Cross Holdings Corporation, SillaJen, Inc., EuBiologics Co., Ltd. and Green Cross Corporation.
The bottom 10 Vaccines companies in South Korea by Price to Earnings Ratio (P/E) are Green Cross Corporation, EuBiologics Co., Ltd., SillaJen, Inc., Green Cross Holdings Corporation, Cellid, Co., Ltd. and SK bioscience Co.,Ltd..